Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Translational Research Group is a private New York limited liability company associated with oncology physician-leader Jeffrey Vacirca. Publicly available descriptions characterize it as a group focused on non-clinical research rather than a therapeutic drug-development company. The entity appears to operate in the broader healthcare and translational research ecosystem, likely supporting research activity adjacent to oncology care networks rather than advancing a disclosed proprietary pipeline. Corporate registry records indicate it is an active domestic LLC in New York. Limited public information is available on its specific services, employees, customers, or commercial programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Translational Research Group.